Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/88150
Title: | GP-OSMOTIC trial protocol : an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice | Authors: | Furler, John O’Neal, David Norman Speight, Jane Blackberry, Irene Manski-Nankervis, Jo-Anne Thuraisingam, Sharmala de La Rue, Katie Ginnivan, Louise Browne, Jessica Lea Holmes-Truscott, Elizabeth Khunti, Kamlesh Dalziel, Kim Chiang, Jason Audehm, Ralph Kennedy, Mark Clark, Malcolm Jenkins, Alicia Josephine Liew, Danny Clarke, Philip Best, James |
Keywords: | Clinical Trials DRNTU::Science::Medicine Primary Care |
Issue Date: | 2018 | Source: | Furler, J., O’Neal, D. N., Speight, J., Blackberry, I., Manski-Nankervis, J.-A., Thuraisingam, S., . . . Best, J. (2018). GP-OSMOTIC trial protocol : an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice. BMJ Open, 8(7), e021435-. doi:10.1136/bmjopen-2017-021435 | Series/Report no.: | BMJ Open | Abstract: | Introduction: Optimal glycaemia can reduce type 2 diabetes (T2D) complications. Observing retrospective continuous glucose monitoring (r-CGM) patterns may prompt therapeutic changes but evidence for r-CGM use in T2D is limited. We describe the protocol for a randomised controlled trial (RCT) examining intermittent r-CGM use (up to 14 days every three months) in T2D in general practice (GP). Methods and analysis: General Practice Optimising Structured MOnitoring To achieve Improved Clinical Outcomes is a two-arm RCT asking ‘does intermittent r-CGM in adults with T2D in primary care improve HbA1c?’ Primary outcome: Absolute difference in mean HbA1c at 12 months follow-up between intervention and control arms. Secondary outcomes: (a) r-CGM per cent time in target (4–10 mmol/L) range, at baseline and 12 months; (b) diabetes-specific distress (Problem Areas in Diabetes). Eligibility: Aged 18–80 years, T2D for ≥1 year, a (past month) HbA1c>5.5 mmol/mol (0.5%) above their individualised target while prescribed at least two non-insulin hypoglycaemic therapies and/or insulin (therapy stable for the last four months). Our general glycaemic target is 53 mmol/mol (7%) (patients with a history of severe hypoglycaemia or a recorded diagnosis of hypoglycaemia unawareness will have a target of 64 mmol/mol (8%)). Our trial compares r-CGM use and usual care. The r-CGM report summarising daily glucose patterns will be reviewed by GP and patient and inform treatment decisions. Participants in both arms are provided with 1 hour education by a specialist diabetes nurse. The sample (n=150/arm) has 80% power to detect a mean HbA1c difference of 5.5 mmol/mol (0.5%) with an SD of 14.2 (1.3%) and alpha of 0.05 (allowing for 10% clinic and 20% patient attrition). | URI: | https://hdl.handle.net/10356/88150 http://hdl.handle.net/10220/45644 |
DOI: | 10.1136/bmjopen-2017-021435 | Schools: | Lee Kong Chian School of Medicine (LKCMedicine) | Rights: | © 2018 Author(s) (or their employer(s)). Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. | Fulltext Permission: | open | Fulltext Availability: | With Fulltext |
Appears in Collections: | LKCMedicine Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
GP-OSMOTIC trial protocol.pdf | 734.21 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
50
8
Updated on Mar 7, 2024
Web of ScienceTM
Citations
20
7
Updated on Oct 24, 2023
Page view(s) 50
475
Updated on Mar 19, 2024
Download(s) 50
76
Updated on Mar 19, 2024
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.